Whyte, Claire S.Morrow, Gael B.Mitchell, Joanne L.Chowdary, PratimaMutch, Nicola J.2020-07-062020-07-062020-07Whyte, C S, Morrow, G B, Mitchell, J L, Chowdary, P & Mutch, N J 2020, 'Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19', Journal of Thrombosis and Haemostasis, vol. 18, no. 7, pp. 1548-1555. https://doi.org/10.1111/jth.148721538-7933PubMedCentral: PMC7264738ORCID: /0000-0001-8127-6102/work/101050691ORCID: /0000-0001-9299-6754/work/116417845ORCID: /0000-0002-7452-0813/work/169538858https://hdl.handle.net/2164/14655Open Access via the Wiley Jisc Agreement With thanks to Wai-Lum Sum from Medical Illustration at the University of Aberdeen with help in compiling figure 2 of the manuscript. British Heart Foundation (GrantNumber(s): FS/11/2/28579, PG/15/82/31721)8821350engFibrinolysisFibrinPlasminogen Activator Inhibitor 1Tissue plasminogen activatorRespiratory distress syndrome (Adult)SARS virusFACTOR XAtissue plasminogen activatorMACROPHAGEACUTE LUNG INJURYPLASMINOGEN-ACTIVATOR INHIBITOR-1respiratory distress syndrome (adult)PNEUMONIAplasminogen activator inhibitor 1INTERLEUKIN-8fibrinolysisELEVATED LEVELSCOAGULATIONfibrinEXPRESSIONTISSUE FACTORR Medicine (General)HematologyBritish Heart FoundationFS/11/2/28579PG/15/82/31721R1Journal article10.1111/jth.14872http://www.scopus.com/inward/record.url?scp=85084616473&partnerID=8YFLogxK187